trial

Action-based Cognitive Remediation for First Episode Psychosis

NCTId NCT03814122
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 13 (actual)
Sponsored by University of Manitoba
Primary completion 2019-06-14
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
13 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Single
Start
2019-02-13
Primary completion
2019-06-14
Eligibility
ALL · 18 Years · 37 Years

Interventions & indications

Drugs
Action-Based Cognitive Remediation

Sponsors

University of ManitobaLead Sponsor
Queen's University, BelfastCollaborator

Investigators

1
Colleen Murphy, PhDPrincipal Investigator

Sites

1 total
Winnipeg, Canada

Facts & assertions

4 sourced
Enrollment
13
Phase
NA
Primary Completion Date
2019-06-14
Status
COMPLETED
relationships
The graph out of here
drug
Action-Based Cognitive Remediation
drug
lead_sponsor
University of Manitoba
company
collaborator
Queen's University, Belfast
company
indication
Psychotic Disorders
indication
Cognitive Impairment
indication
Psychosis
indication
investigator
Colleen Murphy, PhD
person